In a trailblazing advancement in cancer therapy, researchers at Korea Advanced Institute of Science and Technology (KAIST) have developed a technology that transforms colon cancer cells into ...

Colorectal cancer breaks the usual immune rules, with certain regulatory T cells linked to improved survival. In many solid ...

Why does colorectal cancer defy the rules of the immune system? In most cancers, more regulatory T cells (Tregs) mean a worse ...

A research team has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into a state resembling normal colon cells without killing them, thus avoiding side ...

The results of the study could improve immunotherapy treatment for patients with colorectal and other barrier-tissue cancers.

Polish scientists have developed and tested a chemical compound that shows strong activity against colorectal cancer cells ...

Colon cancer remains a major global health concern, ranking third among the most diagnosed cancers and leading causes of cancer-related death worldwide. One critical factor that makes treating colon ...

FDA approves CBI-1214 for colorectal cancer, enabling fast-tracked clinical trials and highlighting innovative T-cell engager ...

Circulating tumor cells (CTCs) have been detected in patients with a variety of solid tumors and may be predictive of prognosis. Although the US Food and Drug Administration has approved some methods ...